Studies to investigate the in vivo therapeutic window of the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY411,575) in the CRND8 mouse (Q48431740)
Jump to navigation
Jump to search
scientific article published on 31 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Studies to investigate the in vivo therapeutic window of the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY411,575) in the CRND8 mouse |
scientific article published on 31 August 2006 |
Statements
1 reference
Studies to investigate the in vivo therapeutic window of the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY411,575) in the CRND8 mouse (English)
1 reference
Lynn A Hyde
1 reference
Nansie A McHugh
1 reference
Joseph Chen
1 reference
Qi Zhang
1 reference
Denise Manfra
1 reference
Amin A Nomeir
1 reference
Hubert Josien
1 reference
Thomas Bara
1 reference
John W Clader
1 reference
Lili Zhang
1 reference
Eric M Parker
1 reference
Guy A Higgins
1 reference
31 August 2006
1 reference
319
1 reference
3
1 reference
1133-1143
1 reference